Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Current Deferred Revenue (2016 - 2018)

Updated

Sigyn Therapeutics (SIGY) reported Current Deferred Revenue of $20,616 for Q3 2018, down 45.4% from the prior quarter.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Current Deferred Revenue (2016 - 2018) Analysis & Trends

At the end of FY2017, Sigyn Therapeutics posted Current Deferred Revenue of $81,455.

  • Per Business Quant data, the three quarters before Q3 2018 came in at $37,726 (Q2 2018), $35,300 (Q1 2018) and $81,455 (Q4 2017).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 20,616.00
Jun 30, 2018 37,726.00
Mar 31, 2018 35,300.00
Dec 31, 2017 81,455.00
Jun 30, 2017 49,612.00
Dec 31, 2016 78,820.00
API Access

Sigyn Therapeutics, Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SIGY&period=max&api_key=YOUR_API_KEY